SERIES DESCRIPTION:

As federal and state investments in research and development grow, universities have sought to bolster the funding they receive from these sources. Increasingly, companies are looking to exploit these opportunities and are turning to universities as logical partners in pursuit of funding. In order to increase the awareness of these programs, the UIDP and NCET2 will hold a series of regularly scheduled webinars that highlight specific agencies and their programs that support university-industry collaborations.

THIS MONTH:

The February 23rd Funding Webinar will focus on the $100 million Small Business Innovation Research (SBIR) grant program of the National Institute of Allergy and Infectious Disease (NIAID). NIAID arose from modest beginnings in 1887 with the establishment of a laboratory at the Marine Hospital on Staten Island, New York. In 1955, after nearly seven decades of growth and evolution, NIAID was given its present name by the United States Congress. The Institute's programs focus on elucidating the causes of infectious and immunologic diseases, and finding innovative means to diagnose, treat, and prevent them. With a budget of about $4.7 billion for fiscal year 2010, NIAID is among the largest of the U.S. National Institutes of Health.

Topics Covered and What Webinar Attendees Can Expect to Gain from Participation:

During this webinar, Dr. Gregory Milman of the National Institute of Allergy and Infectious Disease (NIAID) will provide advice on the Small Business Innovation Research (SBIR) and Small Business Technology Transfer Research (STTR) programs at the National Institutes of Health (NIH). Participants will obtain general guidance and information about these competitive grant opportunities for U.S. small businesses. In order to get the most value from this Webinar, participants are strongly encouraged to review Dr. Milman's SBIR/STTR tutorials in advance. These can be accessed at the following URL: http://funding.niaid.nih.gov/ncn/sbir/pres.htm



_______________________


COST: Free, but registration required.

HOW TO PARTICIPATE?: This series is online. You need a computer with web access for the visual/audio. Q&A is conducted by a chat box to the speakers.

WHO SHOULD PARTICIPATE IN THE WEBINAR?: These webinars are open to anyone interested in how universities and industry can seek funding for their collective efforts . This can include university chief research officers, directors of economic development, corporate business development directors and academic liaisons, university professors and corporate researchers.

_______________________


Dr. Gregory Milman
(Office for Innovation and Special Programs in the National Institute of Allergy and Infectious Diseases (NIAID))

Bio

Dr. Gregory Milman is Director of the Office for Innovation and Special Programs in the National Institute of Allergy and Infectious Diseases (NIAID). He manages the $100 million NIAID small business programs and is acclaimed for his advice on NIH grant preparation and research funding. Dr. Milman was Assistant Professor of Biochemistry at the University of California, Berkeley from 1970-1976, Associate Professor of Biochemistry and Immunology at Johns Hopkins University from 1976-1988, and visiting Professor in Honors at the University of Maryland College Park from 1997-2000. In 1985, he obtained NIH SBIR funding to start a biotechnology company focusing on viral diagnostics. From 1988-1999, Dr. Milman managed the NIAID $70 million basic AIDS research program. He established the NIH Centers for AIDS Research (CFARs) and the NIH AIDS Reagent Program. From 1997 to 2000, Dr. Milman organized the NIH Bioengineering Consortium (BECON) and acted as its first Executive Secretary. In 2000, Dr. Milman was on the NIH staff in President Clinton's White House Office of Science Policy. Dr. Milman has served on the Board of Directors of the Biotechnology Industry Organization Council of Biotechnology Centers, the Maryland Governor's Commission on the Development of Advanced Technology Business, and the Advisory Board for the National Institute of Science and Technology (NIST) Advanced Technology Program (ATP).


_______________________


Don Gerhart, Ph.D.
(Associate Vice President, Research and Innovation, University of Oregon)

Bio

Don Gerhart is Associate Vice President for Research and Innovation at the University of Oregon (UO), where he works to foster university-industry collaboration and to link UO research with innovation, entrepreneurship, and regional economic development. A marine scientist by training, Don holds seven U.S. patents and recently created a marine biotechnology startup company. Before moving to Oregon in 2000, Don worked at the interface of academia and industry in North Carolina for nearly 14 years, serving as a researcher at the Duke University Marine Laboratory, as a specialist in technology transfer and industry research at North Carolina State University, and in various leadership roles with an RTP‑based pharmaceutical development firm. Don currently serves on the Economic Development Council and Entrepreneurial Advisory Board of the Eugene Chamber of Commerce. At the state level, he serves on the Board of Directors of the Oregon Translational Research and Drug Development Institute; in addition, he is technical advisor to the Oregon Innovation Council and serves on the Council’s Capital Formation Committee. At the national level, Don is a member of the Public Policy Advisory Committee of the Association of University Technology Managers, and serves as UO’s representative to the University-Industry Demonstration Partnership. He has been an invited speaker at numerous national and international conferences, including the annual meeting of the National Association of Seed and Venture Funds and the National Academy of Sciences Conference on Marine Biotechnology. Don received his B.A. from the Johns Hopkins University and his Ph.D. from Stony Brook University.